NCT06712303 is a clinical trial of MRI ,ct in Ear Disease, Inner, sponsored by Assiut University.

Who is sponsoring NCT06712303?

NCT06712303 is sponsored by Assiut University.

What drugs are being tested in NCT06712303?

Interventions in NCT06712303: MRI ,ct.

What condition does NCT06712303 study?

NCT06712303 studies Ear Disease, Inner.

Is NCT06712303 still recruiting?

NCT06712303 is currently not yet recruiting. Last updated 2 December 2024.

Last reviewed 2024-12-02 · How we verify

NCT06712303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Multi-detector CT and MRI in Diagnosis of Congenital Inner Ear Anomalies

Not yet recruiting Last updated 2 December 2024

What this trial tests

trial testing MRI ,ct in Ear Disease, Inner in 26 participants. Not yet recruiting.

Timeline

20 December 2024

Primary endpoint
20 December 2026

20 December 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	26
Start date	20 December 2024
Primary completion	20 December 2026
Estimated completion	20 December 2027

Drugs / interventions tested

MRI ,ct

Conditions studied

Ear Disease, Inner — all drugs for Ear Disease, Inner →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Ear Disease, Inner. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of combined value of Multi-detector computed tomography (MDCT) and Magnetic resonance imaging (MRI) in the diagnosis of congenital abnormalities of the inner ear and internal auditory canal in patients with congenital hearing loss and preoperative evaluation of cochlear implant candidates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06712303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 2 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing